Timber Pharmaceuticals, Inc. announced the appointment of David Cohen, M.D. and Lubor Gaal, Ph.D. to its board of directors. Dr. Cohen is the Charles C. and Dorothea E. Harris Professor of Dermatology at New York University School of Medicine, where he also serves as Chief of Allergy and Contact Dermatitis, Vice Chairman of Clinical Affairs, and Director of Occupational and Environmental Dermatology. He was a founding board member for the American Acne and Rosacea Society and previously served as President of the American Dermatological Association, the American Contact Dermatitis Society, the Dermatology Section of the New York Academy of Medicine, and the New York Dermatological Association. Dr. Gaal brings more than two decades of business development, external innovation, and licensing experience in biotechnology and biopharmaceuticals. He is currently Senior Vice President and Head of Europe for Locust Walk where he is responsible for executing licensing, M&A, and financing transactions for biopharma companies around the globe.